Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel

• Status: Completed
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a multi center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: BioPharmX, Inc.
• Treatments: Minocycline

Criteria

Inclusion Criteria:

• moderate to severe inflammatory non-nodular acne vulgaris

Exclusion Criteria:

• female subject who is breastfeeding, pregnant or planning a pregnancy during the study

• have other skin condition or disease that would interfere with the study

• have had any prior treatment with minocycline

• have a known or suspected allergy to tetracycline class products

• have used OTC medications for the treatment of facial acne within the last 14 days

• have used any prescription topical or oral medications for the treatment of facial acne in the last 28 days

• have had a facial procedure (chemical peel, dermabrasion, laser, etc) within the last 8 weeks